Amgen (AMGN) Inventory Average (2009 - 2026)

Amgen's Inventory Average history runs 17 years deep, the most recent figure standing at $6.2 billion for Q1 2026.

• In Q1 2026, Inventory Average fell 9.59% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 9.59% YoY), while the FY2025 annual figure was $6.6 billion, down 19.94% from the prior year.
• Inventory Average was $6.2 billion for Q1 2026 at Amgen, down from $6.3 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $9.1 billion in Q1 2024 to a low of $4.2 billion in Q1 2022.
• Historically, Inventory Average has averaged $6.2 billion across 5 years, with a median of $6.3 billion in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory Average jumped 83.5% in 2024, then fell 24.75% in 2025.
• A 5-year view of Inventory Average shows it stood at $4.8 billion in 2022, then jumped by 50.14% to $7.3 billion in 2023, then dropped by 1.27% to $7.2 billion in 2024, then fell by 12.46% to $6.3 billion in 2025, then fell by 1.27% to $6.2 billion in 2026.
• The last three Inventory Average figures came in at $6.2 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.5 billion (Q3 2025), per Business Quant data.